China Court Rules Against Bayer In Xarelto Clinical Trial Case
This article was originally published in PharmAsia News
Executive Summary
Beijing Chaoyang District Feb. 21 ruled against Bayer and ordered Bayer to compensate the plaintiff, who participated in a Xarelto clinical trial.